Validating quantitative PCR assays for cfDNA detection without DNA extraction in exercising SLE patients
Abstract Circulating cell-free DNA (cfDNA) has been investigated as a screening tool for many diseases. To avoid expensive and time-consuming DNA isolation, direct quantification PCR assays can be established. However, rigorous validation is required to provide reliable data in the clinical and non-...
Guardado en:
Autores principales: | Elmo W. I. Neuberger, Alexandra Brahmer, Tobias Ehlert, Katrin Kluge, Keito F. A. Philippi, Simone C. Boedecker, Julia Weinmann-Menke, Perikles Simon |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2c8625c02e284cb487322ebbc35471f4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fragmentomic cfDNA Patterns in Noninvasive Prenatal Testing and Beyond
por: Kavish Kohabir, et al.
Publicado: (2021) -
Highly sensitive detection of driver mutations from cytological samples and cfDNA in lung cancer
por: Kazutaka Fujita, et al.
Publicado: (2021) -
Kinetics of plasma cfDNA predicts clinical response in non-small cell lung cancer patients
por: Xiaorong Zhou, et al.
Publicado: (2021) -
Oncological evaluation in the perioperative period using cfDNA with BRAF V600E mutation in patients with colorectal cancer
por: Keita Tanaka, et al.
Publicado: (2021) -
Adaptor Template Oligo-Mediated Sequencing (ATOM-Seq) is a new ultra-sensitive UMI-based NGS library preparation technology for use with cfDNA and cfRNA
por: Thomas L. Dunwell, et al.
Publicado: (2021)